Long-term outcome of Graves’ orbitopathy following treatment with sirolimus
Treatment with sirolimus is followed by a greater overall response of GO compared with methylprednisolone at 24 weeks, but not at 48 weeks, when only CAS is affected. A more prolonged period of treatment may be required for a better outcome to be observed over a longer period.
Authors
- Michele Marinò (ORCID: https://orcid.org/0000-0003-0365-116X)
- Maria Novella Maglionico (ORCID: https://orcid.org/0000-0003-4302-9201)
- Giada Cosentino
- Francesco Latrofa (ORCID: https://orcid.org/0000-0003-0297-5904)
- Francesca Menconi (ORCID: https://orcid.org/0000-0003-2100-3123)
- Ferruccio Santini (ORCID: https://orcid.org/0000-0002-1706-0822)
- Giulia Lanzolla (ORCID: https://orcid.org/0000-0001-9933-4040)
- Chiara Posarelli (ORCID: https://orcid.org/0000-0003-0222-5177)
- Simone Comi
- Michele Figus (ORCID: https://orcid.org/0000-0003-2243-9033)
- Roberto Rocchi
Institutions
- University of Pisa (IT)
- Azienda Ospedaliera Universitaria Pisana (IT)
- University of Pennsylvania (US)
Publication Details
- Journal
- Journal of Endocrinological Investigation
- Published
- 2024-10-07
- DOI
- https://doi.org/10.1007/s40618-024-02470-8
- Citations
- 12
- Primary Topic
- Ophthalmology and Eye Disorders
- Type
- article
- Field-Weighted Citation Impact
- 5.10
Funders
- Università di Pisa